Chondroitium sulfate is a high molecular weight mucopolysaccharide that slows the resorption of bone tissue and reduces the loss of calcium ions (Ca2 +). It improves the phosphorus-calcium metabolism in the cartilaginous tissue, accelerates the processes of its restoration, inhibits the processes of degeneration of the cartilaginous and connective tissue.Suppresses enzymes that cause damage to cartilaginous tissue, stimulates the synthesis of glycosaminoglycans, promotes the regeneration of the articular bag and the cartilaginous surfaces of the joints, increases the production of intra-articular fluid. Due to its structural affinity for heparin, it prevents the formation of fibrin clots in the synovial and subchondral microcirculatory bed. Reduces soreness and increases the mobility of affected joints.
Slows the progression of osteoarthritis and osteochondrosis.
Dimethyl sulfoxide, which is part of the drug, promotes better penetration of chondroitin through cell membranes.